Tier E: European SpecialistVenture Capital
Forbion
HQ
Naarden, Netherlands
Founded
2006
AUM
$3B
Portfolio
3 companies
AI × Biotech Thesis
European biotech investor with strong oncology and rare-disease platform exposure, including AI drug-discovery crossovers.
Verified Investments
3 companies- argenx (early, exited)
- Staten Biotech
- Dyno Therapeutics (co-investor)
· Dot indicates company has a profile page on biotech.today
Active Partners
1 on record- Sander SlootwegManaging Partner